Therapeutic Advances Series
World-leading open access journals in clinical medicine
Sage’s Therapeutic Advances series of clinical journals was launched in 2008. Now comprising 20 journals, the Therapeutic Advances family has established itself as a high-quality gold open access series with internationally renowned Editorial Boards.
Many of the journals now have Impact Factors that place them in the first quartile in their respective fields; most are indexed in the Web of Science and other scholarly indexing services, and all are listed on PubMed soon after launch.
The journals are members of the Committee on Publication Ethics (COPE) and have stringent standards for research ethics and reporting. All articles undergo a thorough editorial evaluation and rigorous peer review, with a minimum of two independent experts. All articles are freely available via PubMed Central and the journal websites, driving high visibility and global exposure.
We invite you to explore the series and to get in touch with our Editors.
Latest journal news
- We are delighted to welcome Lauren Kelly, Bushra Mahdi, Jemima Williamson and Josh Gazmin to the Therapeutic Advances Team!
- The Editors of Therapeutic Advances in Endocrinology and Metabolism are delighted to welcome Dr. Srikanth Bellary, Aston University, Birmingham, UK as the new Deputy Editor-in-Chief of our journal.
- Therapeutic Advances in Medical Oncology has built a new sub-section of its Editorial Board – its Editorial Review Board – to help speed up peer-review while ensuring that quality of reviewer reports and journal ethical standards are upheld to the highest degree.
- The Therapeutic Advances journals now publish video abstracts, plain language summaries and infographics alongside journal articles. Speak to the journal’s Editor to find out more.
- The Therapeutic Advances series no longer accepts preclinical research, including basic laboratory research and animal studies
- The Therapeutic Advances journals now accept Plain Language Summaries of Publications. You can find out more here: Plain Language Summaries
Explore our journals

Therapeutic Advances in Allergy and Rhinology
Impact Factor: 2.2

Therapeutic Advances in Cardiovascular Disease
Impact Factor: 2.3

Therapeutic Advances in Chronic Disease
Impact Factor: 3.5

Therapeutic Advances in Drug Safety
Impact Factor: 4.4

Therapeutic Advances in Endocrinology and Metabolism
Impact Factor: 3.8

Therapeutic Advances in Gastroenterology
Impact Factor: 4.2

Therapeutic Advances in Gastrointestinal Endoscopy
Impact Factor: 2.6

Therapeutic Advances in Hematology
Impact Factor: 3.4

Therapeutic Advances in Infectious Disease
Impact Factor: 5.7

Therapeutic Advances in Medical Oncology
Impact Factor: 4.9

Therapeutic Advances in Musculoskeletal Disease
Impact Factor: 4.2

Therapeutic Advances in Neurological Disorders
Impact Factor: 5.9

Therapeutic Advances in Ophthalmology
Impact Factor: 2.5

Therapeutic Advances in Psychopharmacology
Impact Factor: 4.22

Therapeutic Advances in Rare Disease
Launched in 2020

Therapeutic Advances in Reproductive Health
Impact Factor: 3.4

Therapeutic Advances in Respiratory Disease
Impact Factor: 4.3

Therapeutic Advances in Urology
Impact Factor: 2.0

Therapeutic Advances in Vaccines and Immunotherapy
Launched in 2013

Therapeutic Advances in Pulmonary and Critical Care Medicine
Impact Factor: 2.0
Meet our managing editors
Sarangi Thattyot Kariyath
Contact via email
Josh Gazmin
Contact via email
Jemima Williamson
Contact via email